Sonoma Pharmaceuticals, Inc. (SNOA)
1.21
-0.02
(-1.63%)
USD |
NASDAQ |
Oct 07, 16:00
1.19
-0.02
(-1.65%)
After-Hours: 20:00
Sonoma Pharmaceuticals EPS Diluted (Quarterly) : -0.0858 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0858 |
| March 31, 2026 | -0.3293 |
| December 31, 2025 | -0.4781 |
| September 30, 2025 | -0.3244 |
| June 30, 2025 | -0.7562 |
| March 31, 2025 | -0.4793 |
| December 31, 2024 | -0.6339 |
| September 30, 2024 | -0.5899 |
| June 30, 2024 | -1.342 |
| March 31, 2024 | -1.367 |
| December 31, 2023 | -1.588 |
| September 30, 2023 | -5.747 |
| June 30, 2023 | -5.746 |
| March 31, 2023 | -5.592 |
| December 31, 2022 | -12.48 |
| September 30, 2022 | -6.559 |
| June 30, 2022 | -5.721 |
| March 31, 2022 | -21.25 |
| December 31, 2021 | -6.130 |
| September 30, 2021 | -0.8532 |
| June 30, 2021 | -10.49 |
| March 31, 2021 | -35.11 |
| December 31, 2020 | -6.092 |
| September 30, 2020 | 1.112 |
| June 30, 2020 | -6.036 |
| Date | Value |
|---|---|
| March 31, 2020 | -19.54 |
| December 31, 2019 | -14.45 |
| September 30, 2019 | -18.27 |
| June 30, 2019 | 10.87 |
| March 31, 2019 | -48.89 |
| December 31, 2018 | -47.33 |
| September 30, 2018 | -78.51 |
| June 30, 2018 | -99.00 |
| March 31, 2018 | -166.99 |
| December 31, 2017 | -130.62 |
| September 30, 2017 | -120.60 |
| June 30, 2017 | -147.60 |
| March 31, 2017 | -111.99 |
| December 31, 2016 | -138.84 |
| September 30, 2016 | -82.80 |
| June 30, 2016 | -109.80 |
| March 31, 2016 | -144.00 |
| December 31, 2015 | -171.00 |
| September 30, 2015 | -99.00 |
| June 30, 2015 | -135.00 |
| March 31, 2015 | -99.00 |
| December 31, 2014 | -621.00 |
| September 30, 2014 | -72.00 |
| June 30, 2014 | -9.00 |
| March 31, 2014 | 893.89 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
| Johnson & Johnson | 2.268 |
| Eli Lilly & Co. | 7.939 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.33M |
| Revenue (Quarterly) | 6.406M |
| Total Expenses (Quarterly) | 6.736M |
| Enterprise Value | 1.288M |
| Gross Profit Margin (Quarterly) | 40.23% |
| Profit Margin (Quarterly) | -5.15% |
| Earnings Yield | -100.6% |
| Normalized Earnings Yield | -100.63 |